A story of hope for young cancer patients. James Morley of Great Britain was diagnosed with Philadelphia positive acute lymphoblastic leukemia and given a 40-50 percent survival rate.
Hopefully this can help many more patients.Posted by The Mirror on Monday, October 5, 2015
Hopefully this can help many more patients.
Shortly after his diagnosis, he was approached to join a research trial for the drug Dasatinib. He would be the first child in the UK to be given the experimental treatment.
His mother Pam said she and her husband had little time to think about it. "James needed to take the first tablet at 5pm that day, so we had to make the decision quickly in order to meet the criteria for the study," she said.
Luckily, they made the right decision. Three years later, James is in remission.
Pam said, "He's doing absolutely amazing now. Compared to how he was just a year ago, he's improved 100 percent."
After living in a bubble for two years, undergoing over 20 types of chemotherapy, and beating his illness, James is back at school.
"I'm very proud to be part of the trial. If people are offered it, they should definitely go for it."
Your life just got exponentially better and more stylish now you've signed up for our newsletter. Fabulousness awaits!